𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia

✍ Scribed by Pamela S. Becker; Hagop M. Kantarjian; Frederick R. Appelbaum; Stephen H. Petersdorf; Barry Storer; Sherry Pierce; Jianqin Shan; Paul C. Hendrie; John M. Pagel; Andrei R. Shustov; Derek L. Stirewalt; Stephan Faderl; Elizabeth Harrington; Elihu H. Estey

Book ID
108677406
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
150 KB
Volume
155
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination chemotherapy with low-dose c
Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia
✍ Wang-Gang Zhang; Fang-Xia Wang; Yin-Xia Chen; Xin-Mei Cao; Ai-Li He; Jie Liu; Xi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 2 views

## Abstract As sensitization of leukemic cells with granulocyte colony‐stimulating factor (G‐csf) can enhance the cytotoxicity of chemotherapy in acute myeloid leukemia (AML), a pilot study was conducted in order to evaluate the effect of G‐csf priming combined with low‐dose chemotherapy in patient

High-dose cytarabine-containing chemothe
High-dose cytarabine-containing chemotherapy with or without granulocyte colony-stimulating factor for children with acute leukemia
✍ Chen, Shu-Huey; Liang, Der-Cherng; Liu, Hsi-Che πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 27 KB πŸ‘ 2 views

We sought to determine the role of granulocyte colony-stimulating factor (G-CSF) as an adjunct therapy in high-dose cytarabine-containing chemotherapy (HD C/T) for children with acute leukemia. Seventeen patients, aged 9 months to 18 years old, 8 ALL and 9 AML, were treated with cytarabine (Ara-C) 1

Continuous drip infusion of low dose cyt
Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy
✍ Nobuhiro Kanemura; Hisashi Tsurumi; Senji Kasahara; Takeshi Hara; Toshiki Yamada πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 106 KB

## Abstract ## Backgrounds and objectives The optimal strategy for the management of elderly patients with acute myeloid leukaemia (AML) is still controversial. We previously reported the effectiveness of low dose cytarabine (Ara‐C) and etoposide (VP‐16) (AV therapy) for those elderly AML patients